Eyelash Hypotrichosis
Conditions
Brief summary
This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
Interventions
Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months
Sponsors
Allergan
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hypotrichosis of the eyelashes * Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months
Exclusion criteria
* Use of any over-the-counter medication(s) for eyelash growth
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Subjects Satisfied With Latisse® | Day 1 | Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Applications of Latisse® Per Week | Day 1 | Number of applications of Latisse® per week as reported by the subjects. |
| Percentage of Subjects Satisfied Wtih Their Eyelashes | Day 1 | Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Hypotrichosis of the Eyelashes Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months | 585 |
| Total | 585 |
Baseline characteristics
| Characteristic | Hypotrichosis of the Eyelashes |
|---|---|
| Age, Continuous | 50.54 Years STANDARD_DEVIATION 9.68 |
| Sex: Female, Male Female | 580 Participants |
| Sex: Female, Male Male | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 155 / 585 |
| serious Total, serious adverse events | 0 / 585 |
Outcome results
Primary
Percentage of Subjects Satisfied With Latisse®
Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.
Time frame: Day 1
Population: Subjects with all study data
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Hypotrichosis of the Eyelashes | Percentage of Subjects Satisfied With Latisse® | 92.48 Percentage of Subjects |
Secondary
Number of Applications of Latisse® Per Week
Number of applications of Latisse® per week as reported by the subjects.
Time frame: Day 1
Population: Subjects with all study data
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Hypotrichosis of the Eyelashes | Number of Applications of Latisse® Per Week | 6.69 Number of Applications | Standard Deviation 1.13 |
Secondary
Percentage of Subjects Satisfied Wtih Their Eyelashes
Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.
Time frame: Day 1
Population: Subjects with all study data
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Hypotrichosis of the Eyelashes | Percentage of Subjects Satisfied Wtih Their Eyelashes | 79.81 Percentage of Subjects |